APA (7th ed.) Citation

Chen, H., Shah, A., Kato, S., Griffin, R., Zhang, S., Pusalkar, S., . . . Zhu, S. X. (2024). Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects. Drug metabolism and disposition, 52(10), 1115-1123. https://doi.org/10.1124/dmd.124.001841

Chicago Style (17th ed.) Citation

Chen, Hao, et al. "Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects." Drug Metabolism and Disposition 52, no. 10 (2024): 1115-1123. https://doi.org/10.1124/dmd.124.001841.

MLA (9th ed.) Citation

Chen, Hao, et al. "Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects." Drug Metabolism and Disposition, vol. 52, no. 10, 2024, pp. 1115-1123, https://doi.org/10.1124/dmd.124.001841.